Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

monafram

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Factor XIIIa (fXIIIa) is a transglutaminase that plays a crucial role in fibrin clot stabilization and regulation of fibrinolysis… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2014
2014
The reversible aggregation of red blood cells (RBCs) continues to be of the basic science and clinical interest. Recently it has… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 6
  • figure 7
2012
2012
There are complex interactions between blood cells, and erythrocytes may enhance platelet aggregation. However, there is a lack… Expand
  • table 1
  • table 2
2012
2012
Platelets are formed elements of blood. Upon activation, they externalize phosphatidylserine, thus accelerating membrane… Expand
2011
2011
Aim. To study of efficacy and safety of glycoprotein IIb/IIIa blocker monafram in acute ST-segment elevation myocardial… Expand
2010
2010
Glycoprotein (GP) llb-llla anagonist monafram is the F(ab)2 fragments of anti GP llb llla monoclonal antibody FraMon (CRC64… Expand
2007
2007
We investigated the influence of glycoprotein (GP) IIIa Leu33Pro polymorphism, platelet GP IIb-IIIa number, and plasma fibrinogen… Expand
2005
2005
The ability of different ligands of glycoprotein (GP) IIb-IIIa (αIIb/β3-integrin) to support platelet aggregation stimulated by… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2005
2005
New glycoprotein (GP) IIb-IIIa antagonist preparation framon (Monafram), is the F(ab')(2) fragment of a monoclonal antibody… Expand
2004
2004
First Russian glycoprotein (GP) IIb-IIIa antagonist, preparation Monafram, is the F(ab')2 fragment of anti-GP IIb-IIIa monoclonal… Expand